A DNA double helix against a colorful background with music scales.
Citeline

BIO-Europe 2025

Look for us at BIO Europe, driving innovation and shaping the future of clinical research. Visit us at booth #C178.

About the event

BIO-Europe Fall is Europe’s premier biopharma partnering conference, bringing together biotech, pharma, and investment leaders from around the globe for strategic networking and collaboration. The program features inspiring keynotes, interactive panels, and targeted workshops, while the exhibit floor highlights cutting-edge technologies and services. Citeline is proud to be part of this important industry event.

Visit us at booth #C178

Learn more and register for the event by visiting the event website.

Our Sessions

NOV 03, 2025
10:30am CET

Staying in Tune or Falling Flat: The State of European Biopharma Innovation

An incisive, data-led dialogue between an industry analyst and journalist exploring Europe’s current innovation strengths, gaps, and global positioning in life sciences. This session sets the stage for a broader reflection on whether Europe is collaborating in harmony or charting a solo course in the biopharma innovation symphony.

SPEAKER
  • Portrait of Daniel Chancellor, Director of Thought Leadership at Citeline.
    Daniel Chancellor VP of Thought Leadership, Norstella
NOV 03, 2025
11am CET

A Symphony or a Solo Act? Europe’s Role in Biopharma’s Future

As global biopharma enters a new era defined by rapid scientific advances, emerging markets, and shifting commercial models, the question looms: can Europe generate the innovation required to stay in the game? In this timely session, two CEOs will offer their perspectives on Europe’s position in the global innovation hierarchy. They will examine the structural strength and critical gaps within the region’s R&D ecosystem, from translational science to venture capital and commercialization pathways. With China investing heavily in next-gen biotech, threatening the US’s lead in scale and investment, and industry paradigms being rewritten, this conversation will tackle the tough question: what must Europe do now to ensure it remains not just relevant, but indispensable, to the future of global healthcare innovation?

SPEAKER
  • Portrait of Daniel Chancellor, Director of Thought Leadership at Citeline.
    Daniel Chancellor VP of Thought Leadership, Norstella

Meet our expert

Portrait of Daniel Chancellor, Director of Thought Leadership at Citeline.

Daniel Chancellor

VP of Thought Leadership, Norstella

Daniel has more than 15 years of experience in the biopharma industry, spanning roles in drug discovery, market analysis, competitive intelligence, and strategic consulting. Beginning his advisory career at Citeline, Daniel now oversees the thought leadership program for Norstella and its constituent companies, producing materials that support clients across a range of hot topics in the biopharma industry. As part of this, Daniel regularly participates in webinars, conferences, and other speaking arrangements, and he has provided expert insights across a wide range of leading industry and business publications. Prior to joining Citeline, Daniel worked as a medicinal chemist at the UK biotech company Summit Therapeutics and graduated with First Class Honors in Natural Sciences from the University of Bath.

Book a meeting
Citeline may contact you about relevant products, services, and content. To opt out of these communications or to manage what you receive, please visit our Preference Center.

Your information will be used in accordance with our Privacy notice.